These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2089049)

  • 21. A paired comparison of cream and ointment-based dithranol in short contact treatment of psoriasis.
    Grattan CE; Christopher AP; Robinson M
    Br J Dermatol; 1987 Feb; 116(2):279-80. PubMed ID: 3828222
    [No Abstract]   [Full Text] [Related]  

  • 22. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V; Müller RH; Junyaprasert VB
    Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dithranol cream.
    Seville RH; Walker GB; Whitefield M
    Br J Dermatol; 1979 Apr; 100(4):475-6. PubMed ID: 378254
    [No Abstract]   [Full Text] [Related]  

  • 24. Twice-daily vs. once-daily inpatient dithranol for psoriasis.
    Kirkup ME; Sabroe RA; Kavanagh GM; Downs AM; Sansom JE; de Berker DA; Dunnill MG; Kennedy CT; Archer CB
    Clin Exp Dermatol; 2002 Nov; 27(8):695-9. PubMed ID: 12472549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Embedding of dithranol in lipid crystals.
    Lindahl A
    Acta Derm Venereol Suppl (Stockh); 1992; 172():13-6. PubMed ID: 1374990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Storage stability of encapsulated ascorbyl palmitate in normal and high amylose maize starches during pasting and spray dryin.
    Bamidele OP; Emmambux MN
    Carbohydr Polym; 2019 Jul; 216():217-223. PubMed ID: 31047060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pustular dermatitis after administration of a too highly concentrated dithranol ointment in seborrhea].
    Ludolph-Hauser D; Michelsen S; Korting HC
    Hautarzt; 1998 Oct; 49(10):781-3. PubMed ID: 9857255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the surfactant properties of ascorbyl palmitate sodium salt.
    Palma S; Lo Nostro P; Manzo R; Allemandi D
    Eur J Pharm Sci; 2002 Jul; 16(1-2):37-43. PubMed ID: 12113889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications.
    Gopinath D; Ravi D; Rao BR; Apte SS; Renuka D; Rambhau D
    Int J Pharm; 2004 Mar; 271(1-2):95-113. PubMed ID: 15129977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psoriasis: the clinical use of "minute therapy" with Cignolin].
    Runne U; Kunze J
    Z Hautkr; 1983 Feb; 58(4):219-29. PubMed ID: 6845794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dithranol in a cream preparation: disperse or dissolve?
    Prins M; Swinkels OQ; Bouwhuis S; de Gast MJ; Bouwman-Boer Y; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2000; 13(5):273-9. PubMed ID: 10940817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined treatment with oral tretinoin and a dithranol paste in psoriasis].
    Pozo Carballido JL
    Actas Dermosifiliogr; 1978; 69(7-8):215-22. PubMed ID: 362835
    [No Abstract]   [Full Text] [Related]  

  • 34. Stability of dithranol in creams.
    Wuis EW; Burger DM; Beelen M; Hekster YA
    Pharm World Sci; 1999 Dec; 21(6):275-7. PubMed ID: 10658238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PHYSICAL AND CHEMICAL STABILITY ANALYSIS OF COSMETIC MULTI- PLE EMULSIONS LOADED WITH ASCORBYL PALMITATE AND SODIUM ASCORBYL PHOSPHATE SALTS.
    Khan H; Akhtar N; Ali A; Khan HMS; Sohail M; Naeem M; Nawaz Z
    Acta Pol Pharm; 2016 Sep; 73(5):1339-1349. PubMed ID: 29638074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of Antraderm stick 1% and 2% with dithranol paste 0.25% and 0.5% respectively in the treatment of psoriasis.
    Eilard U; Edin L
    Br J Clin Pract; 1985 Jun; 39(6):232-4. PubMed ID: 4041349
    [No Abstract]   [Full Text] [Related]  

  • 37. [Modified dithranol minute therapy of psoriasis vulgaris].
    Chlebarov S; Rauh M
    Z Hautkr; 1988 Aug; 63(8):658-62. PubMed ID: 3188606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilization of dithranol in topical formulations.
    Thoma K; Holzmann C
    Acta Pharm Hung; 1998 Nov; 68(6):313-21. PubMed ID: 9987194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Christensen OB; Holst R; Hradil E; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
    Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
    J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.